Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1996-7-31
pubmed:abstractText
Antisense oligonucleotides can vary significantly and unpredictably in their ability to inhibit protein synthesis. Libraries of chimeric oligonucleotides and RNase H were used to cleave and thereby locate sites on human multidrug resistance-1 RNA transcripts that are relatively accessible to oligonucleotide hybridization. In cell culture, antisense sequences designed to target these sites were significantly more active than oligonucleotides selected at random. This methodology should be generally useful for identification of potent antisense sequences. Correlation between oligonucleotide activity in the cell culture assay and in an in vitro RNase H assay supports the proposed role of the enzyme in the mechanism of antisense suppression in the cell.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-1352874, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-1680858, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2176835, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2202383, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2438160, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2446263, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2501870, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2576349, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-2905169, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-3027054, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-3313277, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-7522907, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-7525971, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-7612196, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-7969490, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-8060991, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-8086420, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-8097969, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-8390996, http://linkedlifedata.com/resource/pubmed/commentcorrection/8657572-8423598
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0305-1048
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1901-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
pubmed:affiliation
DuPont Merck Research Laboratories, Wilmington, DE 19880-0400, USA.
pubmed:publicationType
Journal Article